These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 33917151)

  • 1. Mevalonate Kinase-Associated Diseases: Hunting for Phenotype-Genotype Correlation.
    Boursier G; Rittore C; Milhavet F; Cuisset L; Touitou I
    J Clin Med; 2021 Apr; 10(8):. PubMed ID: 33917151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Twists and turns of the genetic story of mevalonate kinase-associated diseases: A review.
    Touitou I
    Genes Dis; 2022 Jul; 9(4):1000-1007. PubMed ID: 35685471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel homozygous variant in PMVK is associated with enhanced IL1β secretion and a hyper-IgD syndrome-like phenotype.
    Jairaman A; Badiger VA; Raj S; Nair KV; Balan S; Narayanan DL
    Clin Genet; 2024 Mar; 105(3):302-307. PubMed ID: 38018277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A possibly new autoinflammatory disease due to compound heterozygous phosphomevalonate kinase gene mutation.
    Yıldız Ç; Gezgin Yıldırım D; Inci A; Tümer L; Cengiz Ergin FB; Sunar Yayla ENS; Esmeray Şenol P; Karaçayır N; Eğritaş Gürkan Ö; Okur I; Ezgü FS; Bakkaloğlu SA
    Joint Bone Spine; 2023 Jan; 90(1):105490. PubMed ID: 36410683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolated neurological presentations of mevalonate kinase deficiency.
    Hoytema van Konijnenburg EMM; Oussoren E; Frenkel J; van Hasselt PM
    JIMD Rep; 2023 Jan; 64(1):53-56. PubMed ID: 36636591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defective Protein Prenylation in a Spectrum of Patients With Mevalonate Kinase Deficiency.
    Munoz MA; Jurczyluk J; Simon A; Hissaria P; Arts RJW; Coman D; Boros C; Mehr S; Rogers MJ
    Front Immunol; 2019; 10():1900. PubMed ID: 31474985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mevalonate kinase deficiency in 2016].
    Galeotti C; Georgin-Lavialle S; Sarrabay G; Touitou I; Koné-Paut I
    Rev Med Interne; 2018 Apr; 39(4):265-270. PubMed ID: 27659743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutational spectrum and genotype-phenotype correlations in mevalonate kinase deficiency.
    Mandey SH; Schneiders MS; Koster J; Waterham HR
    Hum Mutat; 2006 Aug; 27(8):796-802. PubMed ID: 16835861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of NLRP3, MVK and TNFRSF1A variants in adult Greek patients with autoinflammatory symptoms.
    Karagianni P; Nezos A; Ioakeim F; Tzioufas AG; Moutsopoulos HM
    Clin Exp Rheumatol; 2018; 36(6 Suppl 115):86-89. PubMed ID: 30418111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel mutations in mevalonate kinase cause disseminated superficial actinic porokeratosis.
    Zhu T; Tian D; Zhang L; Xu X; Xia K; Hu Z; Xiong Z; Tan J
    Br J Dermatol; 2019 Aug; 181(2):304-313. PubMed ID: 30597534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perinatal manifestation of mevalonate kinase deficiency and efficacy of anakinra.
    Peciuliene S; Burnyte B; Gudaitiene R; Rusoniene S; Drazdiene N; Liubsys A; Utkus A
    Pediatr Rheumatol Online J; 2016 Mar; 14(1):19. PubMed ID: 27012807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of mevalonate-5-phosphate using UPLC-MS/MS for determination of mevalonate kinase activity.
    Reitzle L; Maier B; Stojanov S; Teupser D; Muntau AC; Vogeser M; Gersting SW
    Clin Biochem; 2015 Aug; 48(12):781-7. PubMed ID: 25982894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular analysis of MVK mutations and enzymatic activity in hyper-IgD and periodic fever syndrome.
    Cuisset L; Drenth JP; Simon A; Vincent MF; van der Velde Visser S; van der Meer JW; Grateau G; Delpech M;
    Eur J Hum Genet; 2001 Apr; 9(4):260-6. PubMed ID: 11313769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mevalonate kinase deficiency: enlarging the clinical and biochemical spectrum.
    Prietsch V; Mayatepek E; Krastel H; Haas D; Zundel D; Waterham HR; Wanders RJ; Gibson KM; Hoffmann GF
    Pediatrics; 2003 Feb; 111(2):258-61. PubMed ID: 12563048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations in the mevalonate kinase (MVK) gene cause nonsyndromic retinitis pigmentosa.
    Siemiatkowska AM; van den Born LI; van Hagen PM; Stoffels M; Neveling K; Henkes A; Kipping-Geertsema M; Hoefsloot LH; Hoyng CB; Simon A; den Hollander AI; Cremers FPM; Collin RWJ
    Ophthalmology; 2013 Dec; 120(12):2697-2705. PubMed ID: 24084495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mevalonate kinase deficiency associated with ataxia and retinitis pigmentosa in two brothers with MVK gene mutations.
    Kellner U; Stöhr H; Weinitz S; Farmand G; Weber BHF
    Ophthalmic Genet; 2017; 38(4):340-344. PubMed ID: 28095071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel mevalonate kinase missense mutation in a patient with disseminated superficial actinic porokeratosis.
    Glinos GD; Pastar I; Giubellino A; Tomic-Canic M; Miteva M; Stone RC
    JAAD Case Rep; 2018 May; 4(4):340-343. PubMed ID: 29693064
    [No Abstract]   [Full Text] [Related]  

  • 18. Hyper-IgD and periodic fever syndrome: a new MVK mutation (p.R277G) associated with a severe phenotype.
    Santos JA; Aróstegui JI; Brito MJ; Neves C; Conde M
    Gene; 2014 Jun; 542(2):217-20. PubMed ID: 24656624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurological manifestations in mevalonate kinase deficiency: A systematic review.
    Elhani I; Hentgen V; Grateau G; Georgin-Lavialle S
    Mol Genet Metab; 2022 Jun; 136(2):85-93. PubMed ID: 35525811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In Silico Prediction of the Effects of Mutations in the Human Mevalonate Kinase Gene: Towards a Predictive Framework for Mevalonate Kinase Deficiency.
    Browne C; Timson DJ
    Ann Hum Genet; 2015 Nov; 79(6):451-9. PubMed ID: 26420133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.